TRS(002567)2025-04-28 16:20Business Performance - The company's operating revenue for 2024 was approximately ¥24.34 billion, a decrease of 9.67% compared to ¥26.95 billion in 2023[31]. - The net profit attributable to shareholders for 2024 was approximately ¥355.42 million, a significant increase of 123.29% from a loss of ¥1.53 billion in 2023[31]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥296.79 million, up 119.72% from a loss of ¥1.51 billion in 2023[31]. - The net cash flow from operating activities for 2024 was approximately ¥936.35 million, representing a 74.83% increase from ¥535.58 million in 2023[31]. - The basic earnings per share for 2024 was ¥0.248, a recovery from a loss of ¥1.0916 in 2023, marking a 122.72% improvement[31]. - The total assets at the end of 2024 were approximately ¥17.99 billion, an increase of 5.75% from ¥17.01 billion at the end of 2023[31]. - The net assets attributable to shareholders at the end of 2024 were approximately ¥5.89 billion, up 7.14% from ¥5.50 billion at the end of 2023[31]. - The company achieved operating revenue of CNY 24.343 billion, a year-on-year decrease of 9.67%[45]. - The net profit attributable to shareholders increased by 123.29% to CNY 355 million[45]. - The company reported a total of 4.3362 million pigs sold, representing a year-on-year growth of 16.80%[45]. Cost Management and Efficiency - The company has implemented a comprehensive disease prevention management system and cost management to enhance production efficiency and reduce costs[13]. - The company is enhancing its production processes by utilizing automated feeding and environmental control systems to improve operational efficiency[13]. - The company has adopted a centralized procurement strategy for raw materials to enhance bargaining power and control costs, ensuring a stable supply chain[10]. - The company reduced the cost of weaned piglets by 46.34 yuan per head compared to the previous year, with expectations for further cost reductions through ongoing investments in breeding and disease control[46]. - The company’s cost of pig fattening decreased by CNY 1.59 per kilogram year-on-year[45]. - The total operating costs decreased by 15.27% to 22,208,823.6 million, with feed costs accounting for 63.31% of total operating costs[73]. Market and Product Development - The company is investing in research and development of meat products to address food safety concerns and improve product quality[15]. - The company is expanding its market presence through strategic partnerships and investments in new technologies[6]. - The company is developing the "Xiangxiang Pig" premium fresh brand through technological innovations in nutrition formulation and breeding, promoting it via both online and offline channels[47]. - The company is focusing on optimizing its digital management system to enhance operational efficiency and decision-making capabilities[17]. - The company plans to expand its "company + farmer" model in regions like Hunan, Guangdong, and Guangxi to enhance profitability[45]. - The company is focusing on new product development, with an investment of 3.49 million in the latest quarter for research and development[109]. Financial Management and Fundraising - The company plans not to distribute cash dividends or issue bonus shares for the current period[18]. - The company has established a comprehensive management system that integrates various operational aspects to ensure steady development[61]. - The company has raised a total of RMB 299,999,997.00 from the issuance of 45,454,545 shares at a price of RMB 6.60 per share, with a net amount of RMB 292,991,294.69 after deducting issuance costs[103]. - The company has a remaining balance of 69,195.04 CNY in unused raised funds, which is stored according to relevant regulations[97]. - The company has redirected RMB 32 million from the "Chongqing Xiangda Biotechnology Co., Ltd. Animal Nutrition Biological Feed Research and Production Base Construction Project" to its subsidiary[114]. Governance and Compliance - The company has established a comprehensive governance structure and internal control system, adhering to relevant laws and regulations to enhance operational standards[145]. - The company is committed to maintaining independent operations, fully separating its business and financial activities from its controlling shareholder[146]. - The company has implemented various internal management systems, including major information reporting and investor relations management[145]. - The company held a total of 6 shareholder meetings in 2024, all conducted legally with the presence of a witnessing lawyer[146]. - The company emphasizes the independence of its operations from controlling shareholders in business, assets, personnel, and finance[150]. Research and Development - The company is focusing on digital transformation to reduce overall breeding costs and improve production and health metrics through AI and IoT technologies[60]. - The company has invested in advanced breeding systems and established partnerships with institutions like the Chinese Academy of Sciences to enhance its breeding capabilities[57]. - The company’s R&D personnel increased to 862 in 2024, a growth of 2.50% compared to 841 in 2023[80]. - R&D investment decreased by 23.34% to ¥101,524,602.56 in 2024 from ¥132,429,246.50 in 2023, representing 0.42% of operating revenue[80]. - The company is committed to enhancing its research and development capabilities in animal nutrition and feed production[119]. Employee Management and Training - The total number of employees at the end of the reporting period is 11,805, with 1,137 in the parent company and 10,668 in major subsidiaries[184]. - The training program in 2024 focused on digital transformation, talent development, and practical skills enhancement, with over 3,093 training sessions covering 120,000 participants and a skill qualification rate of 98%[188]. - The company has implemented a stock option incentive plan, with 403 participants eligible for 6,126,520 stock options in the second exercise period and 50 participants eligible for 822,100 stock options in the first reserved exercise period[193]. - The company emphasizes a "learning organization" ecosystem to support high-quality development through continuous training optimization[188]. - The company's compensation policy is based on annual business plans and performance contributions, aiming for external competitiveness and internal fairness[185].